Synoptic procedural reporting to improve quality indicators in systematic Staging Endobronchial Ultrasound (EBUS) in Non-small cell lung cancer (NSCLC)
- Sponsor:
- University of Melbourne
- Sponsor Study ID:
- 104203
- CTO #:
- 104203
- NCT Number:
- Phase:
- I
- Protocol Type:
- Basic Science
- Age Group:
- Adults
- Disease Sites:
- Lung
- Study Objectives:
- Evaluate whether the implementation of a synoptic report for EBUS results in improved patient outcome metrics, specifically: Proportion of patients with suspected or confirmed non-small cell lung cancer (NSCLC) undergoing systematic staging who have a complete procedure. Where a complete procedure is defined as examination of the five mediastinal lymph node stations (lymph node stations 7, 2R, 4R, 2L and 4L) and sampling of lymph nodes 5mm or larger or those with suspicious morphology as determined by the proceduralist. An incomplete procedure is defined as an systematic staging procedure that does not examine all 5 lymph node stations and sample all that should be sampled as per the above criteria. Proportion of patients with PET-occult lymph node mestases detected. Number of lymph nodes sampled per procedure. Number of patients with at least one radiologically normal lymph node sampled.
- eConsent:
- Not available
- Study Documents:
-
Open Study Documents
(MUSC NetID required for document access)
For more information about this trial please contact the study team:
-
Medical University of South Carolina
- Principal Investigator, Gilbert, Christopher, at gilberch@musc.edu
- Study Coordinator, Balassone, Michael, at balassom@musc.edu
Trial opened at the following institutions:
Medical University of South Carolina